Murry P, Torrecuadrada J L
CH de Saint-Egrève.
Encephale. 1997 Sep;23 Spec No 4:17-9.
For the authors, the creative abilities of a schizophrenic patient are indicators of the therapeutic efficacy of an antipsychotic treatment and the incidence of adverse effects. The new antipsychotic drugs available, unlike conventional neuroleptics, show enhanced efficacy and do not exacerbate the negative symptoms. They may even alleviate them. With regard to clozapine, the authors illustrate the foregoing by two examples of a favorable course in two patients. Clozapine induced an indisputable clinical improvement and hence the opportunity for undeniable artistic activity. Lastly, the new antipsychotics contribute to changing the image that we have of schizophrenic patients.
对于作者而言,精神分裂症患者的创造力是抗精神病治疗疗效和不良反应发生率的指标。现有的新型抗精神病药物与传统抗精神病药物不同,显示出更高的疗效且不会加重阴性症状。它们甚至可能减轻这些症状。关于氯氮平,作者通过两名患者病情好转的两个例子来说明上述情况。氯氮平带来了无可争议的临床改善,从而为无可否认的艺术活动创造了机会。最后,新型抗精神病药物有助于改变我们对精神分裂症患者的看法。